Famar

Executive Summary

Famar is a leading European CDMO with over 75 years of experience, operating 7 production sites and 2 R&D centers across Europe. The company provides end-to-end pharmaceutical services, including R&D, formulation, manufacturing, packaging, and distribution, serving over 80 international markets. As a private company, Famar benefits from long-standing client relationships and a diversified portfolio in small molecules and drug delivery. The CDMO sector is experiencing steady demand driven by outsourcing trends, though competition is intense. Famar's established infrastructure and regulatory expertise position it as a reliable partner, but growth may be limited by capacity constraints and the need for continuous investment in new technologies.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new manufacturing capacity expansion at one of its European sites70% success
• TBDMajor long-term contract win with a top global pharma company50% success
• TBDCompletion of a strategic acquisition to broaden service offerings or geographic reach40% success